News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
EW Healthcare Partners, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Sold 46,778 shares
@ $14.6187, valued at
$683.8k
Sold 121,103 shares
@ $13.0543, valued at
$1.6M
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 50.7% stake in Venus Concept, Inc. |
| 07/13/2023 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Bought 500,000 options to buy
@ $4, valued at
$2M
|
|
| 05/24/2023 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 42% stake in Venus Concept, Inc. |
| 05/17/2023 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Bought 280,899 options to buy
@ $0 |
|
| 11/29/2022 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 40.6% stake in Venus Concept, Inc. |
| 11/28/2022 |
SC 13D/A
| EW Healthcare Partners, L.P. reports a 41.4% stake in Venus Concept, Inc. |
| 11/22/2022 |
4/A
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Bought 1,441,985 options to buy
@ $2, valued at
$2.9M
Bought 58,015 options to buy
@ $2, valued at
$116k
|
|
| 11/22/2022 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Bought 1,441,985 options to buy
@ $2, valued at
$2.9M
Bought 58,015 options to buy
@ $2, valued at
$116k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/18/2020 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Converted 5,191,147 shares
@ $0
Converted 208,853 shares
@ $0
Converted 519,115 preferred shares
@ $0
Converted 20,885 preferred shares
@ $0 |
|
| 03/20/2020 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Bought 519,115 preferred shares
@ $25, valued at
$13M
Bought 3,893,360 options to buy
@ $3.5, valued at
$13.6M
Bought 20,885 preferred shares
@ $25, valued at
$522.1k
Bought 156,640 options to buy
@ $3.5, valued at
$548.2k
|
|
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/08/2019 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on Venus Concept Inc.|
Txns:
| Granted 3,202,053 shares
@ $0
Granted 128,827 shares
@ $0
Granted 2,104,941 shares
@ $0
Granted 84,687 shares
@ $0
Granted 1,439,437 shares
@ $3.75, valued at
$5.4M
Granted 57,911 shares
@ $3.75, valued at
$217.2k
Granted 17,301 options to buy
@ $7.05, valued at
$122k
Granted 1,439,437 warrants
@ $6, valued at
$8.6M
Granted 57,911 warrants
@ $6, valued at
$347.5k
|
|
| 11/08/2019 |
3
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 3 on Venus Concept Inc. |
| 02/13/2019 |
SC 13G/A
| Essex Woodlands Fund IX, L.P. reports a 7.1% stake in AXOGEN, INC. |
| 02/13/2019 |
SC 13D/A
| Essex Woodlands Fund IX, L.P. reports a 44.2% stake in EyePoint Pharmaceuticals, Inc. |
| 02/13/2019 |
5
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 5 on EyePoint Pharmaceuticals, Inc. |
| 07/03/2018 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Bought 16,211,822 shares
@ $1.265, valued at
$20.5M
Bought 652,244 shares
@ $1.265, valued at
$825.1k
Bought 16,211,822 warrants
@ $1.265, valued at
$20.5M
Bought 652,244 warrants
@ $1.265, valued at
$825.1k
|
|
| 04/02/2018 |
4
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Bought 8,273,461 shares
@ $1.1, valued at
$9.1M
Bought 332,863 shares
@ $1.1, valued at
$366.1k
|
|
| 04/02/2018 |
3
| EW Healthcare Partners, L.P. (10% Owner) has filed a Form 3 on EyePoint Pharmaceuticals, Inc. |
| 11/21/2017 |
4
| Essex Woodlands Fund IX, L.P. (10% Owner) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Sold 1,150,000 shares
@ $19.74, valued at
$22.7M
|
|
| 10/28/2016 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
| 07/18/2016 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
| 09/02/2015 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|